Casgevy’s approval changed the sickle cell disease landscape. Developed by Vertex Pharmaceuticals and CRISPR Therapeutics, the therapy showed that the disease could be tackled at its genetic root, ...

Researchers have used modified CRISPR to silence the extra chromosome 21 in Down syndrome cells, showing promising ...

There has been a swing towards in vivo CAR-T therapies lately, as big pharmas sign acquisition deals and new therapies hit ...

Discover the emerging class of degrader-antibody conjugates – a modality that is drawing increasing interest from biotech ...

We take a closer look at Gilead's pipeline strategy and dealmaking activity in 2026 as the company attempts to broaden its ...

Single-cell analysis is reshaping drug discovery, but interpretation remains slow. AI single cell approaches may close the ...

AACR 2026 saw thousands gathered in San Diego, California, where major progress in cancer research was revealed.

Scientists, biochemists, and R&D leaders in pharma and biotech seeking to harness AI to drive innovation, improve efficiency, and stay ahead in drug development. He is the author of two books and 11 ...

Keep up with biotech layoffs in 2026! Each week, the Labiotech team tracks and analyzes layoffs across the biotech industry, offering a clear, data-driven view of trends affecting companies, ...